Drug Database
Back to search

United States· US:61010-6700_10dff217-0d5f-cc47-e063-6294a90a632d

Single Antibiotic with Neomycin

A neomycin product containing neomycin sulfate, registered in United States by Safetec of America. The same ATC class is registered in 6 of our 19 countries.

ATC D06AX04US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedSingle Antibiotic with NeomycinATCD06AX04REGISTER NO.US:61010-6700_10dff21…PACKS LISTED4CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about neomycin sulfateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Neomycin is registered in 6 of 19 countries.

Countries holding a registration under ATC D06AX04 (neomycin), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 3 of them publish a price we can compare per daily dose
Search neomycin products by name

Neomycin · ATC D06AX04

6 / 19 countries

  • Finlandprice
  • Germany
  • Ireland
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
NEOMYCIN SULFATE
Manufacturer
Safetec of America
Country
United States (US)
ATC code
D06AX04
ATC class
Neomycin
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 4

  • ndc11
    61010-6700-2
  • ndc11
    61010-6700-3
  • ndc11
    6101067002
    144 POUCH in 1 BOX (61010-6700-2) / .9 g in 1 POUCH (61010-6700-1)
  • ndc11
    6101067003
    25 POUCH in 1 BOX (61010-6700-3) / .9 g in 1 POUCH (61010-6700-1)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

19 interactions on record for neomycin.

Graded by severity as the source publishes them — 19 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check neomycin against other medicinesHow interaction checks work

Neomycin · interactions on record

19 records

  • 19 moderate

Most severe, free to view

  • StreptomycinA07AA04moderate
  • KanamycinA07AA08moderate
  • StreptomycinJ01GA01moderate
  • TobramycinJ01GB01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Neomycin in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All neomycin products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Germany · Myacyne, Neomycinsulfat Smartpractice Europe
  • Spain · Neomicina
  • Poland · Neomycinum, Neomycinum Tzf

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f6cbaf67-ae17-407d-a028-78c94db21e0b
GET /v1/drugs/f6cbaf67-ae17-407d-a028-78c94db21e0b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "TOPICAL",
  "source": "ndc",
  "strength": "3.5",
  "substance": "NEOMYCIN SULFATE",
  "productndc": "61010-6700",
  "dosage_form": "OINTMENT",
  "dea_schedule": null,
  "strength_unit": "mg/g",
  "application_number": "M004",
  "marketing_category": "OTC MONOGRAPH DRUG"
}
API referenceMCP serverPlans

See everything about neomycin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console